ReviewJournal of multidisciplinary healthcare2026
A Review of the Use of Mobile Health Interventions in Patients with Inflammatory Bowel Disease.
Review in Journal of multidisciplinary healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The management of inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, presents significant challenges due to its chronic, relapsing nature. Mobile health (mHealth) technologies, leveraging smartphones and wearable devices, offer innovative approaches to support long-term care. This narrative review synthesizes current evidence on the use of mHealth interventions in IBD management. This narrative review draws on representative literature identified through a search of PubMed, Embase, and Web of Science (2010-2023). It explores various forms, including health applications, wearable devices, and telemedicine, and their roles in symptom monitoring, medication adherence, dietary management, and psychological support. Synthesized findings from clinical studies indicate that these tools can contribute to improved disease control, adherence rates, and quality of life. The review also discusses key challenges such as data privacy, implementation barriers, and digital literacy, while highlighting future directions involving artificial intelligence for personalized care and interdisciplinary collaboration. Overall, mHealth presents a promising avenue to enhance patient-centered IBD management, though its integration into routine care requires addressing technological, regulatory, and user-centric considerations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.